NCT02629237

Brief Summary

  1. 1.Investigate degree of postoperative satisfaction in county level hospital glaucoma patients.
  2. 2.Investigate the effect of educational intervention affect the degree of satisfaction in glaucoma patients.
  3. 3.Investigate the effect factors of postoperative satisfaction.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 14, 2015

Completed
6.2 years until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

September 27, 2021

Status Verified

September 1, 2021

Enrollment Period

2.6 years

First QC Date

October 9, 2015

Last Update Submit

September 21, 2021

Conditions

Keywords

glaucoma surgeryeducational interventionsatisfactionrural

Outcome Measures

Primary Outcomes (1)

  • The mean satisfaction score over three follow-up visits

    The primary outcome is the mean satisfaction score calculated by adding up the satisfaction scores at three follow-up visits: 1 week, 2 week and 4 week after surgery and dividing the total by the number of scores. The satisfaction score was assessed as a cumulative score. Composite outcome, in which multiple end points are combined, are frequently used as primary outcome measures in randomized trials and are often associated with increased statistical efficiency, although such measure may prove challenging for the interpretation of results. (Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA. 2003; 289: 2554-2559)

    1 week, 2 week and 4 week after surgery.

Secondary Outcomes (5)

  • The rate of willingness to recommend surgery to a friend or relative with glaucoma

    1 week, 2 week and 4 week after surgery.

  • Personality in both groups using Eysenck Personality Questionnaire-Revised Short Scale for Chinese (EPQ-RSC) access glaucoma patients personality

    before surgery

  • Knowledge scores about glaucoma

    before surgery and 1 week, 2 week and 4 week after surgery

  • Intraocular pressure in both groups

    before surgery and 1 week, 2 week and 4 week after surgery

  • visual acuity in both groups

    before surgery and 1 week, 2 week and 4 week after surgery

Study Arms (2)

Multifaceted education group

EXPERIMENTAL

Subjects will be asked to watch a 5-10 min education film and participate in a 10-15 min counseling session with a trained doctor/nurse before glaucoma surgery,and at 1 week and 2 week after surgery.

Other: Multifaceted education

control group

NO INTERVENTION

Subjects will not be asked to watch education film and not participate in counseling session before and after surgery.

Interventions

Subjects will be asked to watch a 5-10 min education film and participate in a 10-15 min counseling session with a trained doctor/nurse before glaucoma surgery,and at 1 week and 2 week after surgery.

Multifaceted education group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age≥18 years, glaucoma patients who do the peripheral iridectomy or trabeculotomy

You may not qualify if:

  • patients who had been the trabeculotomy, vision≤0.05, severe psychotic disorders and dysgnosia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Blindness Preventment and Treatment Department

Guangzhou, Guangdong, 510060, China

Location

MeSH Terms

Conditions

GlaucomaPersonal Satisfaction

Condition Hierarchy (Ancestors)

Ocular HypertensionEye DiseasesBehavior

Study Officials

  • Nathan Congdon, MD,MPH

    The Key Laboratory,Zhongshan Ophthalmic Center,Sun Yat-sen University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
vice directior,Blindness Prevention and Treatment Department

Study Record Dates

First Submitted

October 9, 2015

First Posted

December 14, 2015

Study Start

March 1, 2022

Primary Completion

October 1, 2024

Study Completion

October 1, 2024

Last Updated

September 27, 2021

Record last verified: 2021-09

Locations